The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,973.00
Bid: 1,971.00
Ask: 1,972.00
Change: 17.00 (0.87%)
Spread: 1.00 (0.051%)
Open: 1,963.00
High: 1,994.00
Low: 1,959.00
Prev. Close: 1,956.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: easyJet Loss Widens While Sage Profit Grows

Fri, 17th May 2019 07:39

LONDON (Alliance News) - Stock prices in London are set to open on a softer note on Friday following a broadly downbeat session in Asia overnight as stocks struggle to brush aside US-China trade fears.In early company news, easyJet reported a widened interim loss and warned on its revenue per seat outturn for the second half, Sage said it saw good organic recurring revenue growth in the first half, and Hikma reported a solid start to the year.IG says futures indicate the FTSE 100 index of large-caps to open 31.01 points lower at 7,322.50 on Friday. The FTSE 100 index closed up 56.56 points, or 0.8%, at 7,353.51 on Thursday.The lower open in London comes despite a solid US session overnight.In the US on Thursday, Wall Street ended in positive territory, with the Dow Jones Industrial Average ending up 0.8%, the S&P 500 up 0.9% and Nasdaq Composite closing 1.0% higher."Wall Street closed higher for a third straight session overnight as solid economic data and robust earnings from the likes of Cisco and Walmart boosted sentiment," said Jasper Lawler at London Capital Group. "Investors put US China trade dispute anxieties behind them and continued to jump back into equities."However, stocks in Asia overnight "struggled to put a tough week behind them", said Lawler, leading to a softer open for Europe.US President Donald Trump earlier in the week declared a national emergency aimed at protecting US communication networks. The executive order declares a national economic emergency that empowers the US government to ban the technology and services of "foreign adversaries" deemed to pose "unacceptable risks" to national security.While no specific countries or companies were named, it follows months of US pressure on Huawei and comes after the US last week increased tariffs to 25% on USD200 billion worth of Chinese products.In Asia on Friday, the Japanese Nikkei 225 index closed up 0.9%. In China, the Shanghai Composite is down 1.8%, while the Hang Seng index in Hong Kong is down 1.1%.In early UK company news, low-cost airline easyJet said it delivered an interim result in line with expectations despite "tougher" trading conditions. Revenue for the half to March 31 grew 7.3% to GBP2.34 billion, though the company's pretax loss widened to GBP272 million from just GBP68 million a year ago. This was as fuel costs rose to GBP602 million from GBP461 million, while crew costs were up to GBP405 million from GBP338 million. Depreciation costs amounted to GBP228 million, versus just GBP95 million a year ago. Revenue per seat fell 6.3%, while headline costs per set fell 3.9%. Looking ahead, the company said revenue per seat at constant currency in the second half is now expected to be slightly down. "This is not helped by the ongoing negative impact of Brexit-related market uncertainty as well as a wider macroeconomic slowdown in Europe," noted easyJet. At the same time, however, headline costs per seat excluding fuel at constant currency are expected to decline. As a result, the company said its profit expectations for the current financial year remain unchanged.Capacity growth in the first half was 15%, set to slow to 7% in the second half of the year. Accounting software firm Sage reported good growth in recurring revenue in its first half, backing its overall annual outlook. Revenue for the half-year to March 31 rose 6.4% to GBP957 million, while pretax profit was up to GBP198 million from GBP171 million. Organic recurring revenue rose 10% to GBP779 million, with total organic revenue up 6.2%.Following this strong start to the year, Sage said it expects organic recurring revenue growth to be at the top end, or even slightly exceed, its guided range of between 8% to 9%. However, SSRS and processing revenue is expected at the lower end or below guidance. On balance, Sage said its expectations for annual revenue remain unchanged. "We are encouraged by the strong start to FY19. Sage's vision is to become a great SaaS company and by focusing on customers, colleagues and innovation we are starting to see evidence of successful strategic execution," said Chief Executive Steve Hare.Sage lifted its interim dividend by 2.5% to 5.79p.Generic drugmaker Hikma Pharmaceuticals said 2019 got off to a good start as it backed its annual outlook. The injectables business is performing well, said Hikma, with strong demand in the US offsetting increased competition. The Generics business also had a buoyant start to the year, while the Branded unit Metro Bank said it raised GBP375 million through a "significantly oversubscribed" placing. The challenger bank placed 75.0 million shares at a price of 500p each, representing a 5.2% discount to its closing price on Thursday. Metro Bank on Thursday said it was aiming to raise GBP350 million."Although we've faced challenges in the past few months, we remain fully focused on providing the outstanding service and convenience that our customers expect of us. This growth capital will enable us to continue to expand the business and implement our strategic initiatives," said Found & Chair Vernon Hill.Hill himself subscribed for 1.0 shares in the placing. Cairn Energy said the first four months of 2019 have seen oil production within guidance. Output thus far in the year has been in line with forecasts of 19,000 to 22,000 barrels of oil per day, with the firm "particularly pleased" with the performance of the Catcher field offshore Scotland, said to be operating ahead of expectations. Cairn said it is fully funded for its planned activities in the year, including spudding the second well at the Lynghaug prospect and its Mexican drilling programme.Restaurant Group said trading is in line with expectations with a strong showing from recently acquired Asian chain Wagamama. Like-for-like sales in the 19 weeks to May 12 were up 2.8%, with total sales up 57%, reflecting the Wagamama buy and new pubs and concessions sites opened in 2018. In the period, Restaurant Group said it saw "strong performances" from Wagamama, which "continued to significantly outperform in its core UK market", and its pub business. The pound continued to trade sub-USD1.28 overnight, quoted at USD1.2785 early Friday, broadly unchanged from USD1.2788 at the London equities close on Thursday.UK Prime Minister Theresa May is fighting to keep her Brexit deal alive to prolong her premiership as her grip on power weakens.She will set out the timetable for her departure in early June after a crucial Commons vote on the agreement she thrashed out with the EU, with defeat likely to hasten her exit from Number 10.May's chances of receiving Labour support for the Withdrawal Agreement Bill appear to be fading, with Jeremy Corbyn's party frustrated at the lack of progress in cross-party talks and the prospect of a new prime minister tearing up any compromise.The prime minister will meet the chairman of the Tory backbench 1922 Committee Graham Brady at the start of June to agree to the details of the leadership contest to succeed her.London Capital Group's Lawler said the possibility of a hard Brexit-leaning prime minister is becoming "more likely" and thus the pound is trading softer as hopes of a soft Brexit fade."The overriding fear for currency traders is that this means that a hard no deal Brexit is back on the table as an option," said Lawler.The economic events calendar on Friday has eurozone inflation readings at 1000 BST.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.